Revamping the FDA

Revamping the FDA

The Journal of Life Sciences

Agency needs to adopt new tools to do its job in the 21st century.

Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA associate commissioner, argues that as the FDA enters its second hundred years, its mission must change to both protect and advance the public health. And in order to do that, the agency that regulates upwards of 25 percent of the U.S. economy needs new tools, new expertise and more funding.

Featured

Cutting Healthcare Spending with Occam's Razor
January 13, 2012  
Plan B Science or Pure Politics
January 1, 2012  
PCORI keeps low profile as it preps markers
December 29, 2011  

Social Networks

Receive latest news & event updates
Provide email below:

Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds